{"id":"https://openalex.org/W2762372979","doi":"https://doi.org/10.1080/00325481.2017.1385365","title":"Can pleiotropic effects of eicosapentaenoic acid (EPA) impact residual cardiovascular risk?","display_name":"Can pleiotropic effects of eicosapentaenoic acid (EPA) impact residual cardiovascular risk?","publication_year":2017,"publication_date":"2017-10-04","ids":{"openalex":"https://openalex.org/W2762372979","doi":"https://doi.org/10.1080/00325481.2017.1385365","mag":"2762372979","pmid":"https://pubmed.ncbi.nlm.nih.gov/28974128"},"language":"en","primary_location":{"id":"doi:10.1080/00325481.2017.1385365","doi":"https://doi.org/10.1080/00325481.2017.1385365","is_oa":false,"landing_page_url":"https://doi.org/10.1080/00325481.2017.1385365","pdf_url":null,"source":{"id":"https://openalex.org/S11800902","display_name":"Postgraduate Medicine","issn_l":"0032-5481","issn":["0032-5481","1941-9260"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Postgraduate Medicine","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5077535835","display_name":"John R Nelson","orcid":"https://orcid.org/0000-0003-2455-0296","observed_orcids":["https://orcid.org/0000-0003-2455-0296"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"John R. Nelson","raw_affiliation_strings":["California Cardiovascular Institute, Fresno, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"California Cardiovascular Institute, Fresno, CA, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074335875","display_name":"Wayne S. True","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210089116","display_name":"Sharp Rees-Stealy Medical Group","ror":"https://ror.org/009erh992","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210089116","https://openalex.org/I4405280159"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Wayne S. True","raw_affiliation_strings":["Sharp Rees-Stealy Medical Group, La Mesa, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sharp Rees-Stealy Medical Group, La Mesa, CA, USA","institution_ids":["https://openalex.org/I4210089116"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051547394","display_name":"Viet T. Le","orcid":"https://orcid.org/0000-0001-6659-5332","observed_orcids":["https://orcid.org/0000-0001-6659-5332"]},"institutions":[{"id":"https://openalex.org/I2803061204","display_name":"Intermountain Medical Center","ror":"https://ror.org/009c06z12","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I108785884","https://openalex.org/I2803061204"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Viet Le","raw_affiliation_strings":["Intermountain Medical Center, Murray, UT, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Intermountain Medical Center, Murray, UT, USA","institution_ids":["https://openalex.org/I2803061204"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5105509687","display_name":"Richard Preston Mason","orcid":"https://orcid.org/0000-0001-5483-1852","observed_orcids":["https://orcid.org/0000-0001-5483-1852"]},"institutions":[{"id":"https://openalex.org/I1283280774","display_name":"Brigham and Women's Hospital","ror":"https://ror.org/04b6nzv94","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I121934306","https://openalex.org/I1283280774","https://openalex.org/I48633490"]},{"id":"https://openalex.org/I136199984","display_name":"Harvard University","ror":"https://ror.org/03vek6s52","country_code":"US","type":"education","lineage":["https://openalex.org/I136199984"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R. Preston Mason","raw_affiliation_strings":["Department of Medicine, Cardiovascular Division, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, MA, USA","Elucida Research, Beverly, MA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Cardiovascular Division, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, MA, USA","institution_ids":["https://openalex.org/I1283280774","https://openalex.org/I136199984"]},{"raw_affiliation_string":"Elucida Research, Beverly, MA, USA","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5077535835"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.4363,"has_fulltext":false,"cited_by_count":28,"citation_normalized_percentile":{"value":0.43385827,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"129","issue":"8","first_page":"822","last_page":"827"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10387","display_name":"Fatty Acid Research and Health","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2916","display_name":"Nutrition and Dietetics"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10387","display_name":"Fatty Acid Research and Health","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2916","display_name":"Nutrition and Dietetics"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10394","display_name":"Lipoproteins and Cardiovascular Health","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12975","display_name":"Paraoxonase enzyme and polymorphisms","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1308","display_name":"Clinical Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/eicosapentaenoic-acid","display_name":"eicosapentaenoic acid","score":1.0},{"id":"https://openalex.org/keywords/icosapent-ethyl","display_name":"icosapent ethyl","score":0.8949999809265137},{"id":"https://openalex.org/keywords/residual-cardiovascular-risk","display_name":"residual cardiovascular risk","score":0.9729999899864197},{"id":"https://openalex.org/keywords/statin-treated-patients","display_name":"statin-treated patients","score":0.8450000286102295},{"id":"https://openalex.org/keywords/hypertriglyceridemia","display_name":"hypertriglyceridemia","score":0.8830000162124634},{"id":"https://openalex.org/keywords/omega-3-fatty-acids","display_name":"omega-3 fatty acids","score":0.9279999732971191},{"id":"https://openalex.org/keywords/atherosclerotic-plaque","display_name":"atherosclerotic plaque","score":0.765999972820282},{"id":"https://openalex.org/keywords/unstable-plaque","display_name":"plaque vulnerability","score":0.8679999709129333},{"id":"https://openalex.org/keywords/inflammation","display_name":"inflammation","score":0.5849999785423279},{"id":"https://openalex.org/keywords/lipid-oxidation","display_name":"lipid oxidation","score":0.621999979019165},{"id":"https://openalex.org/keywords/phospholipid-membranes","display_name":"phospholipid membranes","score":0.7200000286102295},{"id":"https://openalex.org/keywords/ldl-cholesterol","display_name":"LDL cholesterol","score":0.6209999918937683},{"id":"https://openalex.org/keywords/triglycerides","display_name":"triglycerides","score":0.7940000295639038},{"id":"https://openalex.org/keywords/reduce-it-trial","display_name":"REDUCE-IT trial","score":0.8339999914169312}],"concepts":[{"id":"https://openalex.org/C2776091944","wikidata":"https://www.wikidata.org/wiki/Q409990","display_name":"Eicosapentaenoic acid","level":4,"score":0.8488868474960327},{"id":"https://openalex.org/C152163801","wikidata":"https://www.wikidata.org/wiki/Q2146057","display_name":"Residual risk","level":2,"score":0.8463635444641113},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7801358699798584},{"id":"https://openalex.org/C2776919658","wikidata":"https://www.wikidata.org/wiki/Q1467339","display_name":"Hypertriglyceridemia","level":4,"score":0.6281383633613586},{"id":"https://openalex.org/C2778913445","wikidata":"https://www.wikidata.org/wiki/Q186319","display_name":"Triglyceride","level":3,"score":0.6198729276657104},{"id":"https://openalex.org/C2778163477","wikidata":"https://www.wikidata.org/wiki/Q43656","display_name":"Cholesterol","level":2,"score":0.5528296828269958},{"id":"https://openalex.org/C2776839432","wikidata":"https://www.wikidata.org/wiki/Q954845","display_name":"Statin","level":2,"score":0.5495896339416504},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5281935930252075},{"id":"https://openalex.org/C3017514745","wikidata":"https://www.wikidata.org/wiki/Q191756","display_name":"Omega 3 fatty acid","level":5,"score":0.4674704074859619},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.43299034237861633},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.36944395303726196},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.35122740268707275},{"id":"https://openalex.org/C543025807","wikidata":"https://www.wikidata.org/wiki/Q61476","display_name":"Fatty acid","level":2,"score":0.3258854150772095},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.20005032420158386},{"id":"https://openalex.org/C2777171753","wikidata":"https://www.wikidata.org/wiki/Q423345","display_name":"Docosahexaenoic acid","level":4,"score":0.17551806569099426},{"id":"https://openalex.org/C19038510","wikidata":"https://www.wikidata.org/wiki/Q2005087","display_name":"Polyunsaturated fatty acid","level":3,"score":0.1691334843635559},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.09220895171165466},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.07902577519416809},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D002318","descriptor_name":"Cardiovascular Diseases","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014280","descriptor_name":"Triglycerides","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D015118","descriptor_name":"Eicosapentaenoic Acid","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D015118","descriptor_name":"Eicosapentaenoic Acid","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D015118","descriptor_name":"Eicosapentaenoic Acid","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D015228","descriptor_name":"Hypertriglyceridemia","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D015228","descriptor_name":"Hypertriglyceridemia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D050197","descriptor_name":"Atherosclerosis","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D050197","descriptor_name":"Atherosclerosis","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":true},{"descriptor_ui":"D050197","descriptor_name":"Atherosclerosis","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D058226","descriptor_name":"Plaque, Atherosclerotic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1080/00325481.2017.1385365","doi":"https://doi.org/10.1080/00325481.2017.1385365","is_oa":false,"landing_page_url":"https://doi.org/10.1080/00325481.2017.1385365","pdf_url":null,"source":{"id":"https://openalex.org/S11800902","display_name":"Postgraduate Medicine","issn_l":"0032-5481","issn":["0032-5481","1941-9260"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Postgraduate Medicine","raw_type":"journal-article"},{"id":"pmid:28974128","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/28974128","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Postgraduate medicine","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320333619","display_name":"Amarin Pharma","ror":"https://ror.org/0353d6x38"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":51,"referenced_works":["https://openalex.org/W182894011","https://openalex.org/W1520609538","https://openalex.org/W1853875009","https://openalex.org/W1856460279","https://openalex.org/W1921371649","https://openalex.org/W1984756098","https://openalex.org/W1988924453","https://openalex.org/W1991038212","https://openalex.org/W2006551863","https://openalex.org/W2009458118","https://openalex.org/W2016517900","https://openalex.org/W2018259829","https://openalex.org/W2025444929","https://openalex.org/W2044165621","https://openalex.org/W2045278676","https://openalex.org/W2048776656","https://openalex.org/W2049641685","https://openalex.org/W2057293475","https://openalex.org/W2082820286","https://openalex.org/W2090609282","https://openalex.org/W2091743718","https://openalex.org/W2092282210","https://openalex.org/W2093598997","https://openalex.org/W2107471253","https://openalex.org/W2113680815","https://openalex.org/W2114867133","https://openalex.org/W2132196134","https://openalex.org/W2138965761","https://openalex.org/W2142347023","https://openalex.org/W2145009492","https://openalex.org/W2151839802","https://openalex.org/W2164324917","https://openalex.org/W2169760772","https://openalex.org/W2171584145","https://openalex.org/W2189339462","https://openalex.org/W2290053204","https://openalex.org/W2314793531","https://openalex.org/W2330486239","https://openalex.org/W2330616215","https://openalex.org/W2336847247","https://openalex.org/W2341439667","https://openalex.org/W2345269362","https://openalex.org/W2347152603","https://openalex.org/W2509312821","https://openalex.org/W2527894800","https://openalex.org/W2548361740","https://openalex.org/W2551778421","https://openalex.org/W2592571300","https://openalex.org/W2596179513","https://openalex.org/W2598498016","https://openalex.org/W2890924764"],"related_works":["https://openalex.org/W1853875009","https://openalex.org/W2592571300","https://openalex.org/W4411706494","https://openalex.org/W4391882617","https://openalex.org/W3195392990","https://openalex.org/W4412724704","https://openalex.org/W3043754526","https://openalex.org/W2970436550","https://openalex.org/W2954882563","https://openalex.org/W2793994473"],"abstract_inverted_index":{"Residual":[0],"cardiovascular":[1],"(CV)":[2],"risk":[3,23,30,35,195],"persists":[4],"even":[5],"in":[6,63,173,191,200],"statin-treated":[7,148,213],"patients":[8,150,214],"with":[9,215],"optimized":[10],"low-density":[11],"lipoprotein":[12],"cholesterol":[13,19],"(LDL-C)":[14],"levels.":[15],"Other":[16],"pathways":[17],"beyond":[18],"contribute":[20],"to":[21,27,46,51,87,132,138,184,197,221,237],"CV":[22,66,141,178,194,240],"and":[24,84,108,124,175],"the":[25,48,52,56,96,109,181,223],"key":[26],"reducing":[28,64,192],"residual":[29,65,140,193,239],"may":[31],"be":[32,198],"addressing":[33],"non-cholesterol":[34],"factors":[36],"through":[37],"pleiotropic":[38],"mechanisms.":[39],"The":[40,68,128,203],"purpose":[41],"of":[42,55,92,147,211,225],"this":[43,174],"review":[44],"is":[45,218],"examine":[47],"literature":[49,69],"relating":[50],"potential":[53,134,224],"role":[54,135,190],"omega-3":[57],"fatty":[58],"acid":[59,61],"eicosapentaenoic":[60],"(EPA)":[62],"risk.":[67,142,241],"shows":[70],"that":[71,119,152],"EPA":[72,86,120,137,153,186,230],"can":[73,187],"robustly":[74],"lower":[75],"plasma":[76],"triglyceride":[77],"(TG)":[78],"levels":[79,83],"without":[80],"raising":[81],"LDL-C":[82],"documents":[85],"have":[88,116],"a":[89,133,189],"broad":[90],"range":[91],"beneficial":[93],"effects":[94],"on":[95,101],"atherosclerotic":[97,110],"pathway,":[98],"including":[99],"those":[100],"lipids,":[102],"lipoproteins,":[103],"inflammation,":[104],"oxidation,":[105],"phospholipid":[106],"membranes,":[107],"plaque":[111,122,126],"itself.":[112],"Clinical":[113],"imaging":[114],"studies":[115],"consistently":[117],"demonstrated":[118,151,172],"decreases":[121],"vulnerability":[123],"prevents":[125],"progression.":[127],"evidence":[129],"therefore":[130],"points":[131],"for":[136],"reduce":[139,238],"A":[143],"large":[144],"randomized":[145],"study":[146,210],"Japanese":[149,177],"ethyl":[154,227,231],"ester":[155],"reduced":[156],"major":[157],"coronary":[158],"events":[159],"by":[160],"19%":[161],"(P":[162],"=":[163],"0.011).":[164],"However,":[165],"while":[166],"there":[167],"has":[168],"been":[169],"significant":[170],"benefit":[171],"another":[176],"outcomes":[179],"study,":[180],"question":[182],"as":[183,233],"whether":[185],"play":[188],"remains":[196],"addressed":[199],"broader":[201],"populations.":[202],"large,":[204],"global,":[205],"ongoing,":[206],"randomized,":[207],"placebo-controlled":[208],"REDUCE-IT":[209],"high-risk":[212],"persistent":[216],"hypertriglyceridemia":[217],"currently":[219],"underway":[220],"investigate":[222],"icosapent":[226],"(high-purity":[228],"prescription":[229],"ester)":[232],"an":[234],"add-on":[235],"therapy":[236]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":12},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2017-10-20T00:00:00"}